uterine cancer
Conditions
Interventions
Patients are randomized between hysterectomy and bilateral salpingo-oophorectomy with vNOTES or conventional laparoscopy.
Sponsors
Catharina Ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: clinical stage 1 low- and intermediate risk endometrial cancer
Exclusion criteria
Exclusion criteria: non-endometrioid endometrial cancer, high stage disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is percentage of women discharged on the of surgery (day 0). We calculated a sample size of 147 women assuming a 30% same day discharge difference with an alpha of 0.05 and a power of 90%. We plan to perform a follow up study of this trial to proof oncological safety of the procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are removal of uterus via allocated technique, major complications, minor complications, operating time, conversion rate, blood loss, hospital stay, usage of analgesics, pain scores, costs and quality of life (QoL). | — |
Countries
Netherlands
Contacts
Public ContactA.S. Tjalsma
Albert Schweitzer Ziekenhuis
Outcome results
None listed